NCT02759159

Brief Summary

Alzheimer's disease (AD) is one of the major brain diseases which received more attention in recent years. The disconnection syndrome is the main pathophysiological mechanism leading to cognitive decline in AD patients. Both animal experiment and clinical observation have demonstrated that acupuncture can generate treatment effect on AD patients by moderating the neural pathway directly. However, the underlying mechanism remains unclear. By using resting state functional magnetic resonance imaging (fMRI) method, as well as acupuncture and neurology sciences, investigators will explore the multi-modality data analysis; compare brain connectivity and network parameters changes between pre- and post- acupuncture treatment; analyze the correlation between fMRI changes and neuropsychology test. The present study aims to elucidate the neural mechanism of acupuncture therapy on early AD, provide theoretical evidence from the perspective of functional connectivity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2016

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2016

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 3, 2016

Completed
29 days until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

October 5, 2016

Status Verified

October 1, 2016

Enrollment Period

2.5 years

First QC Date

April 14, 2016

Last Update Submit

October 4, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • brain functional connectivity

    GE750 3.0T gradient-echo single-shot echo plannar imaging TR=2000ms TE=30ms slice=36 slice thickness=3mm gap=1mm volumes=180

    with in first week after the whole acupuncture treatment

Study Arms (4)

AD-true acupuncture

EXPERIMENTAL

True acupuncture at the "four-gate"acupoints will be administered on AD patients

Procedure: true acupuncture

AD-sham acupuncture

SHAM COMPARATOR

Sham acupuncture at the "four-gate"acupoints will be administered on AD patients

Procedure: sham acupuncture

Mild Cognitive Impairment(MCI)-true acupuncture

EXPERIMENTAL

True acupuncture at the "four-gate"acupoints will be administered on MCI patients

Procedure: true acupuncture

MCI-sham acupuncture

SHAM COMPARATOR

Sham acupuncture at the "four-gate"acupoints will be administered on MCI patients

Procedure: sham acupuncture

Interventions

acupuncture at the "four-gate"acupoints, three times per week and last for 6 months

AD-true acupunctureMild Cognitive Impairment(MCI)-true acupuncture

acupuncture at the places 1cm from the true "four-gate "acupoints,three times per week and last for 6 months

AD-sham acupunctureMCI-sham acupuncture

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Alzheimer's Disease Clinical diagnosis of MCI due to Alzheimer's Disease Drug therapy regularly

You may not qualify if:

  • Frontotemporal dementia Lewy body dementia Vascular dementia Severe depression Brain vascular disease Metabolic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Xuanwu hospital

Beijing, Beijing Municipality, 100053, China

RECRUITING

Dongfang Hospital,Beijing University of Chinese Medicine

Beijing, Beijing Municipality, China

NOT YET RECRUITING

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Radiology Department

Study Record Dates

First Submitted

April 14, 2016

First Posted

May 3, 2016

Study Start

June 1, 2016

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

October 5, 2016

Record last verified: 2016-10

Locations